Induction of serine racemase expression and D-serine release from microglia by secreted amyloid precursor protein

Shengzhou Wu1, Anthony S Basile, Steven W Barger

  • 1Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.

Insights

Amyloid beta and microglia activation in Alzheimer's disease (AD) increase D-serine levels, contributing to excitotoxicity and neuronal death. This links neuroinflammation to neurodegeneration in AD.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Alzheimer's disease (AD) is characterized by neuronal loss and synaptic density reduction.
  • Neuronal death in AD can be linked to excitotoxicity, a process involving overstimulation of neurons.
  • Amyloid beta-peptide (Abeta) has been implicated in releasing glutamate and D-serine, NMDA-R co-agonists.

Purpose of the Study:

  • To investigate the role of secreted amyloid precursor protein (sAPP) in D-serine production by microglia.
  • To elucidate the molecular mechanisms underlying sAPP-induced D-serine production.
  • To extend the understanding of the link between neuroinflammation and excitotoxicity in AD pathogenesis.

Main Methods:

  • Culturing microglia and treating them with sAPP.
  • Measuring D-serine levels in conditioned medium.
  • Analyzing serine racemase gene expression and protein levels using promoter-reporter assays and mRNA analysis.

Main Results:

  • Conditioned medium from sAPP-treated microglia showed elevated D-serine levels.
  • sAPP treatment increased serine racemase protein levels in microglia.
  • Serine racemase was transcriptionally induced by sAPP, as indicated by promoter-reporter and mRNA analyses.

Conclusions:

  • sAPP, a protein fragment involved in AD, induces D-serine production in microglia.
  • This induction occurs via transcriptional regulation of the serine racemase gene.
  • D-serine, in conjunction with glutamate, may mediate the link between neuroinflammation and excitotoxicity in Alzheimer's disease and other neurodegenerative conditions.